Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease.
- DOI
- 10.1111/apt.71062
- Published
- 2026 Oct 25
- Container
- Alimentary pharmacology & therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/apt.71062,
title = {Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease.},
author = {Mohamedi JA and Hoffert Y and Geukens N and Rahier JF and Louis E and Baert F and Dewint P and Lambrecht G and Bossuyt P and Sangeda RZ and Ferrante M and Franchimont D and Liefferinckx C and Dreesen E},
year = {2026},
journal = {Alimentary pharmacology \& therapeutics},
doi = {10.1111/apt.71062},
url = {https://doi.org/10.1111/apt.71062}
}RIS
TY - JOUR TI - Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease. AU - Mohamedi JA AU - Hoffert Y AU - Geukens N AU - Rahier JF AU - Louis E AU - Baert F AU - Dewint P AU - Lambrecht G AU - Bossuyt P AU - Sangeda RZ AU - Ferrante M AU - Franchimont D AU - Liefferinckx C AU - Dreesen E PY - 2026 JO - Alimentary pharmacology & therapeutics DO - 10.1111/apt.71062 UR - https://doi.org/10.1111/apt.71062 ER -
APA
JA, M., Y, H., N, G., JF, R., E, L., F, B., P, D., G, L., P, B., RZ, S., M, F., D, F., C, L., & E, D. (2026). Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease.. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.71062
Source records
- pubmed · retrieved 2026-11-10T05:28:36.039Z